Invesco Nasdaq Biotechnology ETFIBBQ
Type
ETF
Peer group
US equity: Healthcare
Net assets
$75.7M
Expense ratio
0.19%
1-year return
+53.3%
3 years, a year
+21.0%
5 years, a year
+6.7%
12-month yield
1.12%
Holdings
267
What it aims to do.
The Invesco Nasdaq Biotechnology ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index (the Underlying Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Invesco Private Prime Fund | 14.29% |
| GILD Gilead Sciences, Inc. | 9.61% |
| VRTX Vertex Pharmaceuticals Inc. | 9.30% |
| AMGN Amgen Inc. | 9.12% |
| REGN Regeneron Pharmaceuticals, Inc. | 6.03% |
| Invesco Private Government Fund | 5.55% |
| ALNY Alnylam Pharmaceuticals, Inc. | 3.28% |
| INSM Insmed Inc. | 2.38% |
| BIIB Biogen Inc. | 2.10% |
| ARGX argenx SE | 1.67% |
More on IBBQ.
- IBBQ overview
- IBBQ holdings
- IBBQ risk
- IBBQ costs
- IBBQ money in and out
- IBBQ share classes
- Compare IBBQ with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.